BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9106782)

  • 1. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations.
    Colamussi P; Trotta F; Ricci R; Cittanti C; Govoni M; Barbarella G; Giganti M; Bajocchi G; Uccelli L; Trevisan C; Piffanelli A
    Nucl Med Commun; 1997 Mar; 18(3):269-73. PubMed ID: 9106782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.
    Colamussi P; Giganti M; Cittanti C; Dovigo L; Trotta F; Tola MR; Tamarozzi R; Lucignani G; Piffanelli A
    Eur J Nucl Med; 1995 Jan; 22(1):17-24. PubMed ID: 7698150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement.
    Lin WY; Wang SJ; Yen TC; Lan JL
    J Nucl Med; 1997 Jul; 38(7):1112-5. PubMed ID: 9225800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.
    Grünwald F; Schomburg A; Badali A; Ruhlmann J; Pavics L; Biersack HJ
    Eur J Nucl Med; 1995 Sep; 22(9):1073-7. PubMed ID: 7588946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
    Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
    Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE).
    Handa R; Sahota P; Kumar M; Jagannathan NR; Bal CS; Gulati M; Tripathi BM; Wali JP
    Magn Reson Imaging; 2003 Nov; 21(9):1033-7. PubMed ID: 14684208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings.
    Chen JJ; Yen RF; Kao A; Lin CC; Lee CC
    Clin Rheumatol; 2002 Nov; 21(6):516-9. PubMed ID: 12447638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99Tcm-HMPAO SPET and 1H-MRS (proton magnetic resonance spectroscopy) in patients with ischaemic cerebral infarction.
    Lauriero F; Federico F; Rubini G; Conte C; Simone I; Inchingolo V; d'Addabbo A
    Nucl Med Commun; 1996 Feb; 17(2):140-6. PubMed ID: 8778638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
    Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
    Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
    Sabbadini MG; Manfredi AA; Bozzolo E; Ferrario L; Rugarli C; Scorza R; Origgi L; Vanoli M; Gambini O; Vanzulli L; Croce D; Campana A; Messa C; Fazio F; Tincani A; Anzola G; Cattaneo R; Padovani A; Gasparotti R; Gerli R; Quartesan R; Piccirilli M; Farsi A; Emmi E; Passaleva A
    Lupus; 1999; 8(1):11-9. PubMed ID: 10025594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview.
    Adelman DC; Saltiel E; Klinenberg JR
    Semin Arthritis Rheum; 1986 Feb; 15(3):185-99. PubMed ID: 3515561
    [No Abstract]   [Full Text] [Related]  

  • 13. [MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations].
    Cotton F; Bouffard-Vercelli J; Hermier M; Tebib J; Vital Durand D; Tran Minh VA; Rousset H
    Rev Med Interne; 2004 Jan; 25(1):8-15. PubMed ID: 14736556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral hypoperfusion detected by SPET in early neuro-Behçet syndrome.
    Trotta F; Bajocchi G; Colamussi P; Sandri G; Ciancio G; Tola MR; Menegale G; Cittanti C; Giganti M; Piffanelli A
    Nucl Med Commun; 1998 Aug; 19(8):777-80. PubMed ID: 9751932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus.
    Appenzeller S; Amorim BJ; Ramos CD; Rio PA; de C Etchebehere EC; Camargo EE; Cendes F; Costallat LT
    Rheumatology (Oxford); 2007 Mar; 46(3):467-72. PubMed ID: 16901949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signs of cerebral atrophy on single-photon emission tomography.
    Wong CO; Meyerrose GE; Sostre S
    Eur J Nucl Med; 1994 May; 21(5):445-8. PubMed ID: 8062851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations.
    Sanna G; Piga M; Terryberry JW; Peltz MT; Giagheddu S; Satta L; Ahmed A; Cauli A; Montaldo C; Passiu G; Peter JB; Shoenfeld Y; Mathieu A
    Lupus; 2000; 9(8):573-83. PubMed ID: 11035431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage.
    López-Longo FJ; Carol N; Almoguera MI; Olazarán J; Alonso-Farto JC; Ortega A; Monteagudo I; González CM; Carreño L
    Lupus; 2003; 12(11):813-9. PubMed ID: 14667096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic manifestations of pediatric systemic lupus erythematosus.
    Steinlin MI; Blaser SI; Gilday DL; Eddy AA; Logan WJ; Laxer RM; Silverman ED
    Pediatr Neurol; 1995 Oct; 13(3):191-7. PubMed ID: 8554655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.